BioCentury
ARTICLE | Clinical News

VIMRxyn: Received regulatory approval in Thailand to begin a Phase Ib trial in 24 infected patients to determine an effective dose with minimal skin photosensit

November 13, 1995 8:00 AM UTC

VIMRx Pharmaceuticals Inc. (VMRX) Product: VIMRxyn, hypericin antiviral Indication: HIV Status: Received regulatory approval in Thailand to begin a Phase Ib trial in 24 infected patients to determine ...